The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis
| Autor: | Huseyin Sancar Bozkurt, Eamonn Mm Quigley |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
animal diseases 030106 microbiology Immunology medicine.disease_cause law.invention 03 medical and health sciences Probiotic Immune system law Immunology and Allergy Medicine Bifidobacterium Coronavirus Pharmacology Gastrointestinal tract biology business.industry Gastrointestinal Microbiome biology.organism_classification Vaccine efficacy medicine.disease 030104 developmental biology business Cytokine storm |
| Zdroj: | International Journal of Immunopathology and Pharmacology. 34:205873842096130 |
| ISSN: | 2058-7384 |
| DOI: | 10.1177/2058738420961304 |
| Popis: | COVID-19 is a viral pandemic that primarily manifests with respiratory distress but may also lead to symptoms and signs associated with the gastrointestinal tract. It is characteristically associated with a hyper-immune response, also referred to as a ‘cytokine storm’. Probiotics are living microorganisms that have been shown to have positive effects on immune response in man with some bacteria; some strains of Bifidobacteria, for example, possess especially potent immune modulating effects. These bacteria have the potential to ameliorate the ‘cytokine storm’ through a differential effect on pro- and anti-inflammatory cytokines. In the management of COVID-19 and other coronovirus-mediated illnesses, probiotic bacteria also have the potential to enhance vaccine efficacy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|